| Authors: |
Cancelas JA; Connell and O'Reilly Families Cell Manipulation Core Facility, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Buckley L; Velico Medical, Beverly, Massachusetts, USA., Leitman SF; Velico Medical, Beverly, Massachusetts, USA., Nestheide S; Hoxworth Blood Center, University of Cincinnati, Cincinnati, Ohio, USA., Gingras L; Velico Medical, Beverly, Massachusetts, USA., Munoz D; Spaulding Clinical Research, West Bend, Wisconsin, USA., Treml A; Versiti Blood Center, Milwaukee, Wisconsin, USA., Post S; Spaulding Clinical Research, West Bend, Wisconsin, USA., Thant M; Hoxworth Blood Center, University of Cincinnati, Cincinnati, Ohio, USA.; Department of Medicine, Division of Hematology-Oncology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Alquist C; Hoxworth Blood Center, University of Cincinnati, Cincinnati, Ohio, USA., Sohn J; Velico Medical, Beverly, Massachusetts, USA., Rugg N; Hoxworth Blood Center, University of Cincinnati, Cincinnati, Ohio, USA., Cap AP; Velico Medical, Beverly, Massachusetts, USA., Popovsky MA; Velico Medical, Beverly, Massachusetts, USA. |